Weekly Funding Opps

Internal

• V Foundation
  V Scholar Cancer Research Grant
  1 page abstracts and NIH biosketches should be sent to Sarah Laye (slaye@som.umaryland.edu) by 4/14/23 for consideration
• V Foundation
  Pediatric V Scholar Cancer Research Grant
  for consideration, please send 1 page abstract and NIH biosketch sent to Sarah Laye @ slaye@som.umaryland.edu no later than 5/5/23
• UMGCCC
  Student/trainee supplements for PIO faculty to mentor undergraduate or high school trainees
  $1,200/trainee to offset expenses (e.g. supplies, stipends)
• V Foundation
  Pediatric Translational Cancer Research Grant
  for consideration, please send 1 page abstract and NIH biosketch sent to Sarah Laye @ slaye@som.umaryland.edu no later than 5/5/23
• NCI
  Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Enhance the Utility of Data Available through the Childhood Cancer Data Initiative (CCDI) Ecosystem
  Application Due: 06/30/23
  If interested in applying, contact Sarah Laye at slaye@som.umaryland.edu
• NCI
  Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Stimulate Research Using Large Language Models to Assist in Cancer treatment Data Extraction From Clinical Reports or Diagnostic Data From Pathology Reports
  Application Due: 07/14/23
  only one applicant per mechanism, please contact Sarah Laye if interested
• NCI
  Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Stimulate Research in Machine Learning and Artificial Intelligence Tools that extract Real-World Data and Evidence from Electronic Health Records at NCI-designated Cancer Centers
  Application Due: 07/14/23
  only one applicant per mechanism, please contact Sarah Laye if interested
• NCI
  Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Establish Proof-ofConcept Federated Learning Frameworks That Will Run Multimodal Artificial Intelligence Models
  Application Due: 07/14/23
  only one applicant per mechanism, please contact Sarah Laye if interested
• UMSOM
  Large Grant Acceleration Program (LGAP)
• V Foundation
  Future V Foundation Opportunities
  contact Sarah Laye for more information at slaye@som.umaryland.edu
• US Department of Veteran Affairs (VA)
  VA opportunities

  If interested in obtaining the PDF version of a particular VA opportunity and to inquire on eligibility, please email Natalie Dugger (Natalie.Dugger@va.gov) and cc Sarah Laye (slaye@som.umaryland.edu) on your request. Note that VA opportunities are specific and you must confirm eligibility with the VA.

  Deadline varies by grant

VA

• US Department of Veteran Affairs (VA)
  CSR&D Merit Review Award (Precision Oncology Actively Managed Portfolio) (I01)
  Application Due: 06/12/23

NIH

• NIH
  Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Enhance the Utility of Data Available through the Childhood Cancer Data Initiative (CCDI) Ecosystem
  Application Due: 06/30/23
  If interested in applying, contact Sarah Laye at slaye@som.umaryland.edu
• NCI
  Interventions to expand cancer screening and preventive services to ADVANCE
  Application Due: 10/05/23
  Standard due dates apply
• NCI
  NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)
  Standard due dates apply
• NIH
  The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed)
  LOI due: 05/01/2023
  Application Due: 06/01/23
  LOI due 30 days before application due date
• NCI
  Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)
  LOI due: 05/02/2023
  Application Due: 06/02/23
• NCCIH
  Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
  Application Due: 06/05/23
  LOI due 30 days before application due date
• NCI
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  Application Due: 06/05/23
  LOI due 30 days before application due date
  Standard due dates apply
• NCCIH
  Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
  Application Due: 06/05/23
• NCI
  Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
  Application Due: 06/05/23
  Standard due dates apply
• NCI
  HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
  Application Due: 06/13/23
• NCI
  Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
  Application Due: 06/14/23
  LOI due 30 days before application due date
• NCI
  Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
  Application Due: 06/15/23
• NIH
  Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional)
  Application Due: 06/20/23
  LOI due 30 days before application due date
• NCI
  NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
  Application Due: 06/20/23
  no LOI required
  Standard due dates apply
• NIH
  Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional)
  Application Due: 06/20/23
  LOI due 30 days before application due date
• NCI
  Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
  Application Due: 06/29/23
  LOI due 30 days before application due date
• NCI
  Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
  Application Due: 06/29/23
  LOI due 30 days before application due date
• NCI
  Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)
  Application Due: 06/30/23
  LOI due 30 days before application due date
• NCI
  Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)
  Application Due: 06/30/23
• NCI
  Cancer Immunoprevention Network (CIP-Net) ​Research Projects (UG3/UH3 Clinical Trials Not Allowed)
  Application Due: 07/03/23
  LOI due 30 days before application due date
• NIH
  Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)
  Application Due: 07/03/23
  LOI due 30 days before application due date
• NCI
  Cancer Immunoprevention Network (CIP-Net) ​Research Projects (UG3/UH3 Clinical Trials Not Allowed)
  Application Due: 07/03/23
  LOI due 30 days before application due date
• NIH
  Emergency Award: RADx-®UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)
  Application Due: 07/10/23
  LOI due 30 days before application due date
• NCI
  NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
  Application Due: 08/08/23
• NCI
  HEAL Initiative Partnerships to Advance INterdisciplinary (PAIN) Training in Clinical Pain Research: The HEAL PAIN Cohort Program (T90/R90 Independent Clinical Trial Not Allowed)
  Application Due: 09/26/23
  LOI due 8/11/2023
• NCI
  Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
  Application Due: 10/05/23
  Standard due dates apply
• NCI
  Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
  Application Due: 10/05/23
• NCI
  Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
  Application Due: 10/16/23
  LOI due 30 days before application due date
  Standard due dates apply
• NIH
  Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed)
  Application Due: 10/19/23
  LOI due 30 days before application due date
  Standard due dates apply
• NCI
  Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
  Application Due: 10/23/23
  LOI due 30 days before application due date
• NCI
  Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
  Application Due: 10/23/23
  LOI due 30 days before application due date
• NIA
  Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed) 
  Application Due: 10/23/23
• NCI
  Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
  Application Due: 12/15/23
  LOI due 30 days before application due date
• NCI
  Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
  Application Due: 06/16/23
  Standard due dates apply

Foundation

• Gray Foundation
  GRAY FOUNDATION BRCA TEAM SCIENCE PROGRAM
• Prostate Cancer Foundation
  Prostate Cancer Foundation Awards (Various)
  Deadlines vary across grants
• The Hope Foundation
  SWOG Trial Support (STrS)
• Union for International Cancer Control UICC
  Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
  opens autumn 2023
• Lung Cancer research Foundation (LCRF)
  LCRF (various)
• American Association for Cancer Research (AACR)
  AACR-ASTRAZENECA CAREER DEVELOPMENT AWARD FOR PHYSICIAN-SCIENTISTS, IN HONOR OF JOSÉ BASELGA
  Application Due: 05/31/23
• The Mark Foundation, The Samuel Waxman Cancer Research Foundation
  The Mark Foundation Aging and Cancer Award
  LOI due: 03/01/2023
  Application Due: 06/01/23
• Israel Cancer Research Fund, Samuel Waxman Cancer Research Foundation
  AGING AND CANCER
  LOI due: 03/15/2023
  Application Due: 06/01/23
• Prostate Cancer Foundation, Bayer
  2023 Bayer-PCF Darolutamide Challenge Awards
  Application Due: 06/05/23
• American Association for Cancer Research (AACR)
  VICTORIA’S SECRET GLOBAL FUND FOR WOMEN’S CANCERS CAREER DEVELOPMENT AWARD, IN PARTNERSHIP WITH PELOTONIA & AACR
  Application Due: 06/07/23
• Duke
  Duke Specialized Program in Research Excellence (SPORE) in Brain Cancer
  Application Due: 06/09/23
• Duke
  Duke Specialized Program in Research Excellence (SPORE) in Brain Cancer Career Enhancement Program (CEP)
  Application Due: 06/09/23
• AASLD Foundation
  THE LIVER MEETING ABSTRACT AWARDS
  Application Due: 06/15/23
• Pfizer
  Pfizer Fellowship Grant RFP Transthyretin Cardiac Amyloidosis Fellowship
  Application Due: 06/20/23
• Multiple Myeloma Research Foundation
  MMRF Myeloma Omics Initiative
  Application Due: 06/30/23
• Prostate Cancer Foundation, Bayer
  023 Bayer-PCF Health Equity Research Awards
  Application Due: 07/10/23
• Damon Runyon Cancer Research Foundation
  Damon Runyon-Dale F. Frey Award for Breakthrough Scientists Overview
  Application Due: 07/14/23
• The Mark Foundation
  The Mark Foundation Emerging Leader Award
  Application Due: 07/24/23
• World Cancer Research Fund International
  INSPIRE Research Challenge
  Application Due: 07/24/23
• NCCN, Pfizer
  NCCN Pfizer Investigator-Sponsored Research Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple Myeloma
  Application Due: 08/02/23
• Elsa U. Pardee Foundation
  Elsa U. Pardee Foundation Grant
  Application Due: 08/31/23
• American Association for Cancer Research (AACR)
  AACR-NOVOCURE CANCER RESEARCH GRANT
  LOI due: 05/30/2023
  Application Due: 09/06/23
• American Association for Cancer Research (AACR)
  AACR-NOVOCURE CAREER DEVELOPMENT AWARD FOR CANCER RESEARCH
  LOI due: 05/30/2023
  Application Due: 09/06/23
• The Lam Foundation
  The Lam Foundation grant Opportunities (various)
  LOI due: 06/15/2023
  Application Due: 09/15/23
  Standard due dates apply
• Gateway for Cancer Research, American Lung Association
  Gateway/American Lung Association Grant
  LOI due: 07/26/2023
  Application Due: 09/16/23
• American Cancer Society
  ACS Clinician Scientist Development Grant (CSDG)
  Application Due: 10/15/23
• American Cancer Society
  RFA: Cancer Health Equity Research Centers
  LOI due: 05/01/2023
  Application Due: 10/16/23
• American Psychological Foundation
  Alice F. Chang Cancer Wellness Grant
  Application Due: 02/01/24

Fellowship

• Memorial Sloan Kettering Cancer Center
  Oncologic Surgical Pathology Fellowship
  Application Due: 06/30/23

• NCI
  Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed)
  LOI due: 06/24/2023
  Application Due: 07/24/23

NCI

• NCI
  National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2024
  Application Due: 08/22/23

NIH NOSI

• NIA
  Notice of Special Interest (NOSI): Alzheimer’s-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimer’s Disease
  Application Due: 10/03/23
• NCI
  Notice of Special Interest (NOSI): Administrative Supplements to Study the Economics of Cancer Control in Low- and Middle-Income Countries (LMICs)
  Application Due: 05/31/23
• NCI
  Request for Information (RFI): Needs and Challenges in Obtaining and Testing Clinical-Grade RNA-based Cancer Vaccine Formulations to Support Translational and Clinical Research
  Application Due: 06/30/23
• NIH
  Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes
  Application Due: 01/08/24
• NCI
  Notice of Special Interest (NOSI): Administrative Supplements to Enhance Institutional Data Science Capacity
  Application Due: 04/02/24
• NCI
  Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments
  Application Due: 05/08/24
• NCI
  Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
  Application Due: 05/09/24
• NIH
  Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health
  Application Due: 05/09/24
• NIH
  Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer
  Application Due: 09/08/24
• NCI
  Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors
  Application Due: 10/09/24
• NIH
  Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute
  Application Due: 11/13/24
• NIH
  Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research
  Application Due: 12/31/24
• NIH
  Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  Application Due: 05/01/25
• NIH
  Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology
  Application Due: 05/07/25
• NIH
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NIH
  Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
  Application Due: 01/08/26
• NIH
  Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
  Application Due: 06/06/26
• NIH
  Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions
  Application Due: 06/06/26
• NIH
  Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities
  Application Due: 06/06/26

NIH RFI

• NCI
  Request for Information (RFI): Seeking Input for National Cancer Institute (NCI) Cancer Adoptive Cellular Therapy (Can-ACT) Network on Clinical Trials Data Planning and Sharing
  Application Due: 06/12/23
• NCI
  Request for Information (RFI): Needs and Challenges in Obtaining and Testing Clinical-Grade RNA-based Cancer Vaccine Formulations to Support Translational and Clinical Research
  Application Due: 06/30/23

DOD

• DOD
  DOD 2023 Breast Cancer Research Program (BCRP)
• DOD
  FY23 DoD Melanoma Grants
  Deadlines vary across awards
• DOD
  DOD Ovarian Cancer, Pilot Award
  Application Due: 07/21/23
• DOD
  DOD Lung Cancer, Translational Research Award
  Application Due: 08/03/23
• DOD
  DOD Lung Cancer, Idea Development Award
  Application Due: 08/03/23
• DOD
  DOD Lung Cancer, Patient-Centered Outcomes and Survivorship Award
  Application Due: 08/10/23
• DOD
  FY23 Ovarian Cancer Research Program (OCRP) (various)
  Deadlines vary across awards
• DOD
  DoD Peer Reviewed Cancer - Career Development Award
  Application Due: 08/10/23
• DOD
  DoD Peer Reviewed Cancer - Patient Well-Being and Survivorship Award
  Application Due: 08/10/23
• DOD
  DoD Peer Reviewed Cancer - Advancing Cancer Care through Clinical Trials Award
  Application Due: 09/27/23

CDC

• CDC - DHHS
  CDC’s National Networks Driving Action: Preventing Tobacco- and Cancer-Related Health Disparities by Building Equitable Communities
  Application Due: 05/31/23
• CDC - DHHS
  National Partnerships to Promote Cancer Surveillance Standards and Support Data Quality and Operations of National Program of Cancer Registries
  Application Due: 06/01/23

DHHS

• DHHS
  Evaluation of linkage to care programs in support of hepatitis C elimination
  Application Due: 07/12/23

COVID

• University of Maryland Baltimore, Institute for Clinical & Translational Research (UMB ICTR)
  Special Call for COVID-19 ICTR Voucher Applications
  Applications will be accepted on a rolling basis.
• NIH
  Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
  Expiration Date: 9/8/24.
• UM VENTURES
  UMCP / UMB Coronavirus Medical Device Challenge Program
  Applications will be accepted on a rolling basis through May 2020 (or until funds are exhausted); funding decisions will be made bi-weekly until all funds are spent.
• UMB SOM Office of Research Career Development
  Funding for Research on COVID-19 and Information for NIH Applicants re: Impact of COVID-19 on Grants and Submissions